Abstracts Archive - Page 504 of 1683 - ATC Abstracts

2020 American Transplant Congress
Glomerular C4d in Post-Transplant IgA Glomerulonephritis is Associated with Decreased Allograft Survival
Z. Kikic, H. Omic, B. Perschl, G. Böhmig, N. Kozakowski, M. Eder
Medical University of Vienna, Vienna, Austria
*Purpose: Post transplant (pTX) glomerulonephritis (GN) is an important factor contributing to early and late allograft failure. De novo or recurrent IgA GN are the…
2020 American Transplant Congress
The Clinical Relevance of cPRA in 0-ABDRDQ Mismatched Kidney Transplants
J. H. Lan¹, D. Chang¹, M. Kadatz¹, J. Gill¹, H. M. Gebel², J. S. Gill¹
¹Medicine, Division of Nephrology, University of British Columbia, Vancouver, BC, Canada, ²Pathology, Emory University, Atlanta, GA
*Purpose: The clinical relevance of immune sensitization as measured by cPRA in kidney transplantation remains uncertain.*Methods: We identified 4,057 adult, first, kidney only transplant recipients…
2020 American Transplant Congress
Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy: A Cross-Sectional Study
Q. Zhang¹, K. Budde¹, D. Schmidt¹, F. Halleck¹, M. Dürr¹, M. Naik¹, M. Mayrdorfer¹, W. Düttmann-Rehnolt¹, F. Klauschen², B. Rudolph², K. Wu²
¹Department of Nephrology, Charité – Universitätsmedizin Berlin, Berlin, Germany, ²Department of Pathology, Charité – Universitätsmedizin Berlin, Berlin, Germany
*Purpose: Proteinuria is common after transplantation. Transplant Glomerulopathy (TG), one of the main causes of post-transplant proteinuria, is also a major contributor to graft loss.…
2020 American Transplant Congress
Late Intra-Patient Tacrolimus Variability Predicts De Novo Donor-Specific Antibody and Graft Loss
J. Lee¹, E. Kim¹, S. Yang², S. Kim¹, H. Choi³, B. Kim⁴, M. Ju⁵, M. Kim², S. Kim², Y. Kim², K. Huh²
¹Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, ²Department of Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁴Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, ⁵Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: Intra-patient variability (IPV) of tacrolimus level has been associated with poor outcomes after kidney transplantation. However, these findings were limited mainly to measurements early…
2020 American Transplant Congress
Comparative Outcome Evaluation of Kidney Donors with and without Sickle Cell Trait
A. Alshaqaq, N. Musaied, A. AlAbadi, M. AlBugami, F. AlOtaibi, K. Hamawi, K. Bel’eed-Akkari
Multi-Organ Transplant Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
*Purpose: Kidney transplant programs in Saudi Arabia (KSA) are predominantly based on living kidney donation. Sickle cell trait (SCT) is prevalent in the Eastern and…
2020 American Transplant Congress
Delayed Graft Function Adversely Affects Long-Term Survival for Kidney Recipients after Non-Renal Solid-Organ Transplantation
J. A. Reyes, C. Blanton, M. Eerhart, G. Leverson, P. Chlebeck, Y. Yankol, L. Fernandez
Surgery, University of Wisconsin, Madison, WI
*Purpose: End-stage renal disease (ESRD) frequently develops after nonrenal solid-organ transplantation, increasing the number of patients with a prior heart, liver or lung transplant on…
2020 American Transplant Congress
Validation of Patient Reported Outcomes Measurement Information System (PROMIS) Computer Adaptive Testing Depression Item Bank in Kidney Transplant Recipients
V. Shah¹, A. Rezaeishahreza¹, E. Lui¹, R. Aser¹, S. Bartlett², M. Li¹, D. Howell¹, J. Peipert³, M. Novak¹, I. Mucsi¹
¹University Health Network, Toronto, ON, Canada, ²McGill University, Montreal, QC, Canada, ³Northwestern University, Chicago, IL
*Purpose: To evaluate the reliability and validity of the PROMIS Depression computerized adaptive test (PROMIS-D CAT) in relation to a legacy measure in adult Kidney…
2020 American Transplant Congress
“By the Time They Get to Me, I’ll Be Dead Anyway” – A Mixed-Methods Examination of Treatment Education & Decision-Making among Patients with Varying Amounts of Pre-End-Stage Renal Disease Nephrology Care
M. Urbanski¹, L. Dumenci¹, C. Gadegbeku², L. Siminoff¹, A. Waterman³, H. Gardiner¹
¹College of Public Health, Temple University, Philadelphia, PA, ²Lewis Katz School of Medicine, Section of Nephrology, Hypertension, and Kidney Transplantation, Temple University, Philadelphia, PA, ³UCLA, Division of Nephrology, Los Angeles, CA
*Purpose: The aim of this study was to explore renal replacement therapy (RRT) knowledge and decision-making experiences and preferences among patients with varying amounts of…
2020 American Transplant Congress
Efficacy and Possible Risk of De Novo Use of Everolimus for Primary Kidney Transplantation
S. Narumi¹, Y. Watarai¹, N. Goto², T. Hiramtsu¹, M. Okada¹, K. Futamura², T. Tomosugi¹, A. Kanda², T. Kobayashi³
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, ²Transplant Nephrology, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, ³Transplant Surgery, Aichi Medical University School of Medicine, Nagakute City, Aichi Prefecture, Japan
*Purpose: Transplant outcome and protocol stay rate of everolimus were investigated to clarify efficacy and risk of everolimus based regimens at a single institute.*Methods: During…
2020 American Transplant Congress
The Safety and Efficacy of 6-Month Steroid Reduction Strategy after Kidney Transplantation: A Prospective Cohort Study
J. Bang, C. Oh, S. Lee
Department of Surgery, Ajou University Medical School, Suwon, Korea, Republic of
*Purpose: In kidney transplantation, immunosuppressive regimens almost always contain corticosteroids for preventing acute rejection and graft loss. However, long-term maintenance of corticosteroids has been associated…